"A 57-subject clinical trial conducted by Advanced Medical Research, with our funding, suggested that consumption of our RiSolubles nutritional supplements may lower blood glucose levels of type 1 and type 2
diabetes mellitus patients and may be beneficial in reducing high blood cholesterol and high blood lipid levels. If warranted, we may develop products which address the use of SRB products as medical foods for, and to potentially make health benefit claims relating to, the effects of dietary rice bran on diabetes and cardiovascular disease."
This next one looks good in conjunction with the protein just out
"In December 2007, we formed Rice Science, LLC (RS), a Delaware limited liability company, with Herbal
Science Singapore PTe. Ltd. (HS) to develop nutraceutical extracts and pharmaceutical chemistries from our SRB. HS utilizes sophisticated methodologies in the identification and isolation of specific biologically active compounds that have been tested for effectiveness against specific disease conditions. In March 2011, our partnership with HS ended with us acquiring the membership interest formerly owned by HS, leaving RS as our wholly owned subsidiary. We are hopeful that the research already performed will result in 29biologically active SRB extracts for use in the nutraceutical and functional food industry."
Gnus is right they are old statements. I thought you would have been posting this one though,
Because of the potential significance for SRB and DRB inclusion in meat and poultry, we have engaged specialized meat and poultry consultants in the U.S. to assist in meat and poultry application research and development, make potential qualified customer introductions, provide marketing support and conduct customer training programs. In addition, we have enlisted the services of a strategic protein application expert from Europe to help research and establish manufacturing processes, identify new SRB and DRB meat applications, and assist our international distributors in key international markets.
Such sweeping global statements for a company that only grew revenues 5% last year. I think those statements might be old news too, if they are referring to the 2008 meat inclusion study done by Gits Prabhu.
Hate to pop your bubble on both of those statements. They have been in the 10-K for 2010, 2011 and now 2012. The only difference I saw was they added "29" this time versus the same sentence with no number in the last two 10-K's. The 57-subject trial had to have been done by March 2011.